StockWatch
·

BERYL DRUGS LTD. Q4 FY26 Results

BERLDRGQ4 FY26 Results
Filing
MetricValue ( Cr)Q3 FY26Q4 FY25
Revenue5.1335.8%29.1%
Total Income5.4742.0%4.8%
Expenditure4.603.2%10.1%
PBT0.87242.4%750.5%
Net Profit0.56435.4%270.3%
OPM19.53%26.72pp38.37pp
NPM10.29%14.65pp7.38pp
EPS1.11236.4%270.0%
View full financials

Informational and educational content only. Not investment advice.